Contrast Media Injectors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Industry Outlook

The contrast media injectors market is set to reach US$ 1155.5 Mn by 2029 from US$ 641.49 Mn in 2020 projecting stable growth at a compounded annual growth rate (CAGR) of 6.8% during the forecast period from 2021 to 2029. Minimal invasive surgeries equipped with contrast media injectors have grabbed prominence in the last 2 decades on account of factors such as increasing number of patients suffering with chronic diseases and rising public health awareness resulting in enhanced preliminary diagnosis.

The advantages associated with contrast media injectors are they provide real time imaging of surgical site and guides the surgeons to conduct safe surgeries of vital organs. The limitations associated with the market growth of contrast media injectors are frequent product recalls and delayed regulatory approvals from healthcare agencies throughout the globe.

Injector systems to dominate the product segment on account of rising demand for computed tomography (CT) and magnetic resonance imaging (MRI)

Injector systems are leading the product segment owing to chief factors such as increasing number of outpatients visiting hospitals to perform preliminary diagnosis and steady rise in the number of clinics and research centers housing well-equipped imaging devices such as computed tomography (CT) scans and magnetic resonance imaging (MRI) etc. Technological advancement in the injector systems has drastically reduced human error and provides high accuracy & efficiency. Consumables will be the fastest growing product segment due to availability of diverse range of tubings and syringes at affordable prices and rapid use of imaging devices results in frequent replacement of consumables to alert physicians of potential hazards such as extravasations and air embolism.

Increasing number of patients suffering with cardiovascular diseases to create a positive traction for interventional cardiology market growth

Interventional cardiology holds the largest market in application segment on account of factors such as rising prevalence of cardiac disorders and increasing demand for visually guided minimal invasive cardiac surgeries. According to World Health Organization (WHO) statistics, annually 17.9 million people die from cardiovascular disease throughout the globe. The major factors responsible for this high mortality are ineffective diagnosis and delayed medical intervention. Radiology will foster exemplary growth during the forecast period owing to prime factors such as increasing number of traumatic and non-traumatic cases throughout the globe and increasing demand for preliminary diagnosis to determine disease etiology and associated treatment regimen.

Well-developed healthcare infrastructure to drive the contrast media injectors market in North America

In the current scenario North America is the leader in the contrast media injectors market with 38% share. The key factors that define its dominance are rising prevalence of chronic diseases and well developed healthcare infrastructure. Domicile of key players such as GE Healthcare and VIVID IMAGING cater the requirement of injector systems for interventional cardiology and radiology. Increasing public health awareness resulting in early diagnosis favors contrast media injectors market growth in North America. In Europe the market growth is driven by increased funding in the research and development of consumables pertaining to contrast media injectors. Healthcare institutions heavily rely upon use of CT scan and MRI for the diagnosis of diseases which serves as a lucrative market for the consumables employed in contrast media injector systems. Asia Pacific will register steady growth during the forecast period on account of key factors such as increasing number of traumatic incidents requiring visual guided surgeries and rapid installation of medical imaging equipment in hospitals and clinics.

Historical & Forecast Period

This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2021 to 2029.

Market assessment is an important tool to understand the existing trends in the contrast media injectors market. Technical innovations pertaining to syringes, injectors, tubing’s etc. are covered in the scope of the report. Merger & acquisition and strategic collaboration among key players are covered by studying the organic and inorganic market growth strategies. The key players manufacturing contrast media injector systems and consumables are APOLLO RT Co., Ltd., Sino Medical-Device Technology Co., Ltd, Bayer Healthcare LLC, GE Healthcare, Guerbet Group, Medtron AG, VIVID IMAGING, Nemoto Kyorindo Co., Ltd., Bracco Group and Ulrich GmbH & Co., KG.

Key questions answered in this report

• Who are the key players providing system injectors and consumables for contrast media injectors market?
• Market assessment and competitive landscape are studied and briefly mentioned in the scope of the report?
• What are the drivers, restraints and opportunities pertaining to the contrast media injectors market?
• Which is the leading and fastest growing product segment in the contrast media injectors market?
• Which is the leading and fastest growing application segment in the contrast media injectors market?
• Which is the leading and fastest growing regional segment in the contrast media injectors market?

This product will be delivered within 2 business days.